A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.
Clinical trial NCT04760990 · COMPLETED
Trial details
- NCT number
- NCT04760990
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-01
- Primary completion
- 2023-12-15
- Enrollment
- 1181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.